“…Ow-dmCpG mapped to a number of genes involved in obesity and metabolism. Notable examples were MAP4K2 or GCK, close to an SNP associated with uric acid and a candidate player in inflammation (Chuang et al, 2016;Lee et al, 2018); IRX2, associated with BMI in women and expressed in an adipose tissue depotdependent fashion (Karastergiou et al, 2013;Ng et al, 2017)-IRX2 promotes cellular differentiation in leukemia and could therefore exert currently unappreciated obesity-related effects in blood cells, for instance by altering the leukocyte repertoire (Scalea et al, 2020); KLF3, a driver of diet-induced obesity in mice which could act by promoting the expression of the adipose browning factor in selected white blood cells (Bell-Anderson et al, 2013;Knights et al, 2020); RREB1, promoting adipose tissue browning (Brunmeir et al, 2016)the RREB1-altered expression in peripheral blood is associated with pediatric obesity (Plaza-Florido et al, 2020); KLHL32, associated with BMI in a blood-based genome-wide association study (Monda et al, 2013); PLOD3 (aka LH3), involved in adiponectin production (Zhang et al, 2015)-peripheral blood PLOD3 expression is altered in obstructive sleep apnea, a condition linked to obesity (Perry et al, 2013); and HVCN1, a driver of reactive oxygen species production in B cells (Capasso et al, 2010). The most significant enrichment was of targets for E47, an activator of adiponectin expression (Doran et al, 2008).…”